Dec 24 (Reuters) - Shares of Agios Pharmaceuticals (AGIO) jumped 18% on Wednesday after the U.S. Food and Drug Administration approved the expanded use of its drug for the treatment of a type of blood disorder.
The drug mitapivat is now approved as a treatment for patients with anemia in both non-transfusion-dependent and transfusion-dependent alpha- or beta-thalassemia, the company said late on Tuesday.
Thalassemia is an inherited blood disorder affecting the body's ability to produce hemoglobin and healthy red blood cells.
The drug, under the brand name Aqvesme, is expected to be available in late January next year, following the implementation of the required safety program.
Mitapivat was already approved by the U.S. FDA in 2022 to treat low red blood cell counts in adults with pyruvate kinase deficiency, under the brand name of Pyrukynd.
"The approval unlocks an additional $320 million in peak revenue opportunity layered atop the existing mitapivat franchise," Truist analyst Gregory Renza said.
The latest approval is based on a late-stage study in which patients receiving mitapivat showed a statistically significant increase in hemoglobin response compared to those on placebo.
Aqvesme will carry a boxed warning for liver function tests every four weeks during the first 24 weeks of treatment and advises against use in patients with cirrhosis, Renza added.
(Reporting by Siddhi Mahatole in Bengaluru; Editing by Vijay Kishore)
latest_posts
- 1
Shredded cheese sold in dozens of states recalled due to potential for metal fragment contamination - 2Step by step instructions to Guarantee the Life span of Your Dental Inserts: Support and Care Guide
- 3A mom stopped giving her kids snacks — and sparked a debate about eating habits
- 4African Forests Have Become a Source of Carbon Emissions
- 5SpaceX launches Starlink satellites on its 150th Falcon 9 mission of the year
- Will your baby get a hep B vaccine? What RFK panel's ruling means.
- 35 million tons of food go to waste yearly in the US. Experts share tips to help stop it
- Tributes pour in for MIT professor Nuno Loureiro amid unresolved shooting case
- They grew up with 'almond moms.' Now, they dread going home for the holidays.
- Can ICE agents detain U.S. citizens? What powers do they have to arrest people? Your most common questions answered.
- 6 Fledgling Cameras for 2024: Ideal for New Photographic artists
- Amid growing bipartisan scrutiny of Pete Hegseth, Trump says he 'wouldn't have wanted … a second strike' on alleged Venezuelan drug boat survivors
- A mom's viral post is raising the question: Do kids need snacks? Dietitians have answers.
- Bennu asteroid samples provide clues about solar system origins and 'space gum'
